ZHANG JIE,SLISKOVIC D. ROBERT,DUCKER CHARLES E.,ZHANG Jie,SLISKOVIC D. Robert,DUCKER Charles E.
申请号：
SI201030979
公开号：
SI2411376T1
申请日:
2010.03.25
申请国别(地区):
SI
年份:
2015
代理人:
摘要：
The invention relates to compounds of formulae (1) and (2): and pharmaceutically acceptable salts thereof for the treatment of cancer, inflammation, auto-immune diseases, diabetes and diabetic complications, infection, cardiovascular disease and ischemia-reperfusion injuries.
